Skeletal Muscle Channelopathies
Gene: SCN4AEnsemblGeneIds (GRCh38): ENSG00000007314
EnsemblGeneIds (GRCh37): ENSG00000007314
OMIM: 603967, Gene2Phenotype
SCN4A is in 14 panels
4 reviews
Fowzan ALKURAYA (King Faisal Specialist Hospital and Research Center)
Reported mutations tend to be missense rather than LOF. PLI is very low in ExAC, which also suggests a disease mechanism other than LOF or haploinsufficiency.Created: 22 Feb 2017, 3:38 p.m.
Publications
Mode of pathogenicity
Other - please provide details in the comments
Variants in this GENE are reported as part of current diagnostic practice
Fowzan ALKURAYA (King Faisal Specialist Hospital and Research Center)
Reported mutations tend to be missense rather than LOF. PLI is very low in ExAC, which also suggests a disease mechanism other than LOF or haploinsufficiency.Created: 22 Feb 2017, 3:31 p.m.
Publications
Mode of pathogenicity
Other - please provide details in the comments
Variants in this GENE are reported as part of current diagnostic practice
Arianna Tucci (Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square)
Mostly missense mutations. two common path mutations: T704M and M1592V (periodic paralysis). A founder mutation (M1476I) in families with paramyotonia congenita.
Reduced penetrance.Created: 10 Jan 2017, 3 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Hyperkalemic periodic paralysis, type 2; Hypokalemic periodic paralysis, type 2; Myotonia congenita, atypical, acetazolamide-responsive; Paramyotonia congenita
Publications
Ellen McDonagh (Genomics England Curator)
Is on the Muscle Channel NGS Panel in the UCLH National Hospital for Neurology and Neurosurgery & Institute of Neurology (NHNN) Neurogenetics genetic testing manual.Created: 10 Jun 2016, 2:47 p.m.
Comment on mode of inheritance: Confirmed on OMIM.Created: 10 Jun 2016, 2:28 p.m.
Comment on list classification: This gene is in the genetic muscle channel diseases section in the UCLH National Hospital for Neurology and Neurosurgery & Institute of Neurology (NHNN) Neurogenetics genetic testing manual, for testing of Paramyotonia Congenita, one of the main skeletal muscle channelopathies.Created: 10 Jun 2016, 2:26 p.m.
Details
- Mode of Inheritance
- MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
- Sources
-
- Expert Review Green
- Eligibility statement prior genetic testing
- UKGTN
- Illumina TruGenome Clinical Sequencing Services
- Radboud University Medical Center, Nijmegen
- Phenotypes
-
- Hyperkalemic periodic paralysis, type 2, 170500
- Myasthenic syndrome, acetazolamide-responsive, 614198
- Hypokalemic periodic paralysis, type 2, 613
- Potassium-Aggravated Myotonia
- Hyperkalemic Periodic Paralysis
- Hypokalemic Periodic Paralysis
- Thyrotoxic Periodic Paralysis, Susceptibility To, 2
- Myotonia
- Episodic weakness
- OMIM
- 603967
- Clinvar variants
- Variants in SCN4A
- Penetrance
- Incomplete
- Publications
- Panels with this gene
-
- Intellectual disability
- Congenital myaesthenic syndrome
- Rhabdomyolysis and metabolic muscle disorders
- Acute rhabdomyolysis
- DDG2P
- Congenital myopathy
- Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies
- Arthrogryposis
- Skeletal Muscle Channelopathies
- Fetal anomalies
- Paroxysmal central nervous system disorders
- COVID-19 research
- Skeletal muscle channelopathy
- Rare syndromic craniosynostosis or isolated multisuture synostosis
History Filter Activity
panel promoted to version 1
Arianna Tucci (Genomics England Curator)Promoted 22/02/2017 after curation discussion and further review with members of the Genomics England curation team.
Gene classified by Genomics England curator
Arianna Tucci (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Set Phenotypes
Arianna Tucci (Genomics England Curator)Phenotypes for SCN4A were set to Hyperkalemic periodic paralysis, type 2, 170500; Myasthenic syndrome, acetazolamide-responsive, 614198; Hypokalemic periodic paralysis, type 2, 613; Potassium-Aggravated Myotonia; Hyperkalemic Periodic Paralysis; Hypokalemic Periodic Paralysis; Thyrotoxic Periodic Paralysis, Susceptibility To, 2; Myotonia; Episodic weakness
Set publications
Arianna Tucci (Genomics England Curator)Publications for SCN4A were set to 17395131; 15534250
Set Mode of Inheritance
Arianna Tucci (Genomics England Curator)Mode of inheritance for SCN4A was changed to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Set Phenotypes
Arianna Tucci (Genomics England Curator)Phenotypes for gene SCN4A were set to Hyperkalemic periodic paralysis, type 2, 170500; Myasthenic syndrome, acetazolamide-responsive, 614198; Hypokalemic periodic paralysis, type 2, 613; Potassium-Aggravated Myotonia; Hyperkalemic Periodic Paralysis; Hypokalemic Periodic Paralysis; Thyrotoxic Periodic Paralysis, Susceptibility To, 2;Myotonia; Episodic weakness
Set Mode of Inheritance
Ellen McDonagh (Genomics England Curator)Mode of inheritance for SCN4A was changed to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Gene classified by Genomics England curator
Ellen McDonagh (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Added New Source
Ellen McDonagh (Genomics England Curator)SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: Eligibility statement prior genetic testing
Added New Source
Eik Haraldsdottir (Genomics England)SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: UKGTN
Set Mode of Inheritance
Eik Haraldsdottir (Genomics England)Model of inheritance for gene SCN4A was changed to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Added New Source
Eik Haraldsdottir (Genomics England)SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: Illumina TruGenome Clinical Sequencing Services
Added New Source
Eik Haraldsdottir (Genomics England)SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: Radboud University Medical Center, Nijmegen